Unlike PKM1, which retains high constitutive PK activity, PKM2’s low activity allows cancer cells to accumulate various glycolytic intermediates necessary for the biosynthesis of nucleic acids, amino acids, and phospholipids, promoting anabolism through the pentose phosphate pathway [36, 37]. This evidence concerns the gene PKM and cancer.